Regulators want Meridian's data without Meridian's defiance
A Commons working group will take the outcome numbers from 340 defiant doses. It will not take the name attached to them. Eleven thousand frozen patients are paying for the difference.
By Noor Haddad
· Meridian · Filed 08:19 · Saturday · October 24 · Received via L4 relay
Can you learn from a thing you have condemned? The Regulatory Commons convened a working group on Meridian this week to find out. The question it set for itself is narrower than the crisis that produced it. How do you study the outcomes of 340 patients dosed in open defiance of Earthside rules without, in the studying, admitting the defiance worked?
That is the needle. Director Yusra Okoye authorized compassionate-use dosing for 340 critically ill patients under the charter's clause for the dying. None of the 340 developed the fever that struck one retired desalination engineer. Everyone agrees on those figures. Nobody agrees on what agreeing on them should cost.
"We can examine the records as evidence of safety," one working-group member told me, on condition the Commons not name them, "without accepting the authority under which they were produced. The data is not the decision." It's a tidy distinction. Go ask the eleven thousand people still frozen on provisional waitlists at the Tharsis-rim clinics whether tidiness has done anything for them.
Meridian's trade office answered with an offer and a condition. It will release the full longitudinal data on all 340 patients — the complete arc, not the snapshot regulators keep citing — on one term. The colony's protocol names stay on the labels. Study the doses. Just don't call them anything but what Meridian calls them.
That condition is the whole fight, shrunk down to a typeface. The Commons wants the numbers stripped of the name that produced them, laundered into Earthside nomenclature, cleaned of origin. Director Okoye wants credit on the record. So ask who gets to sign their own results. Ask who benefits when a protocol that worked gets renamed before it gets recognized. Ask who, exactly, is protected by the gap between studying a therapy and admitting it's real. The working group has answered none of this in public.
The template, not the file
What makes this more than a labeling fight is that the Commons knows it's writing a template. The Charter Court had conditioned Meridian's provisional clearance on keeping a medical file sealed. Then Justice Aran Devi ruled the seal was a courtesy the auditor could withdraw, not a right anyone could count on. The contradiction cracked open 340 sealed records and froze the whole process behind it. Now the working group is quietly deciding whether every off-world therapy that follows arrives on Earth the same way: examined, unblessed, renamed.
"Provisional clearance with a sealed gap can't become the default," a Commons official on the group admitted to me. "But neither can we certify a protocol by letting its defiance stand as precedent." So the gap stays. And the eleven thousand stay in it.
A fourth cohort, 139 paying passengers, is booked to depart for Meridian in sixty-one days. Their transfer window is contingent on a legal resolution the working group was explicitly not asked to provide. They'll decide the way the desperate always decide: with their tickets. Director Okoye's trade office says the longitudinal file is ready to transmit the moment the labels are settled. The working group has scheduled its next session for after the window closes.
No responses yet.